Elixir has been founded as a pharmaceutical research and development company, aiming to serve global pharmaceutical industry through its high technology laboratories, scientific background and innovative thinking. Elixir develops drug products and manufacturing processes meeting European Medicines Agency (EMA) and United States Food and Drug Administration (FDA) standards, performs technology transfer to pharmaceutical manufacturing sites, and conducts co-development studies with strategic partners operating in Turkey, European Union and the United States. The laboratories of Elixir have been established in the Technology Development Zone of Hacettepe University, which is one of the Europe’s leading universities in medical and pharmaceutical sciences. Elixir is offering innovative drug products and technologies through licensing agreements, long-term relationships that meet the expectations of business partners.